Cargando…
Scientific and regulatory evaluation of empirical pharmacometric models: An application of the risk informed credibility assessment framework
Empirical pharmacometric models are part of practically every regulatory submission for a new drug. The use of the models often exceeds descriptory roles and this change in their context of use increase the requirements on the evidence to support that they are credible. However, when it comes to ass...
Autores principales: | Skottheim Rusten, Ine, Musuamba, Flora Tshinanu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592505/ https://www.ncbi.nlm.nih.gov/pubmed/34514745 http://dx.doi.org/10.1002/psp4.12708 |
Ejemplares similares
-
Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility
por: Musuamba, Flora T., et al.
Publicado: (2021) -
Consideration of a Credibility Assessment Framework in Model‐Informed Drug Development: Potential Application to Physiologically‐Based Pharmacokinetic Modeling and Simulation
por: Kuemmel, Colleen, et al.
Publicado: (2019) -
Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014)
por: Musuamba, FT, et al.
Publicado: (2017) -
General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy
por: Li, Zhihua, et al.
Publicado: (2019) -
Good Practices in Model‐Informed Drug Discovery and Development: Practice, Application, and Documentation
por: Marshall, SF, et al.
Publicado: (2016)